FINWIRES · TerminalLIVE
FINWIRES

BOM:539523

3 stories mentioning BOM:539523Updated 30d ago

Every FINWIRES story that references BOM:539523, newest first.

Research

Bob Capital Markets Downgrades Alkem Laboratories to Sell From Hold; Price Target is INR4,638

Alkem Laboratories (NSE:ALKEM, BOM:539523) has an average rating of overweight and mean price target of 6,012.48 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

BOM:539523NSE:ALKEM
Asia

Jefferies Adjusts Alkem Laboratories' Price Target to INR6,500 From INR6,550, Keeps at Buy

Alkem Laboratories (NSE:ALKEM, BOM:539523) has an average rating of overweight and mean price target of 6,012.48 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

BOM:539523NSE:ALKEM
Asia

Alkem Laboratories Gets 7 Observations from US FDA After Daman Plant Inspection

Alkem Laboratories (NSE:ALKEM, BOM:539523) said it has received Form 483 with seven observations from the U.S. Food and Drug Administration after inspection of its manufacturing facility in Daman, India, according to a Saturday filing on Indian bourses.Shares of the company fell nearly 1% in Monday's trade.The inspection was conducted from April 20 to May 1, the filing said.The company said it will respond to the observations within the specified timeframe.

BOM:539523NSE:ALKEM

Track with the FINWIRES app suite